Want to see IN:IOLCP full AI Analyst Report?
IOL Chemicals & Pharmaceuticals Ltd. (IOLCP) Stock Price & Analysis
IOLCP Stock Chart & Stats
- Day’s Range
- INR 176.00 - INR 186.35
- 52-Week Range
- INR 67.14 - INR 224.00
- Previous Close
- INR 184.85
- Volume
- 410.76K
- Average Volume (3M)
- 183.74K
- Market Cap
- INR 52.17B
- Enterprise Value
- INR 20.69B
- Total Cash (Recent Filing)
- INR 2.00B
- Total Debt (Recent Filing)
- INR 0
- Price to Earnings (P/E)
- 31.1
- Beta
- 1.51
- Next Earnings
- Feb 09, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Feb 17, 2026
- Dividend Yield
- 0.56%
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet
Very low leverage gives IOLCP financial resilience and preserves flexibility to fund operations or pursue growth without relying heavily on external financing. The sustained increase in equity further strengthens its capacity to absorb business volatility over the next several quarters.
Diversified Chemicals And APIs Platform
Exposure to both pharmaceutical ingredients and industrial chemicals broadens IOLCP’s customer and application base. Its presence across APIs, intermediates, and specialty products can support more durable demand and reduce reliance on a single end market.
Reported Earnings Growth
The reported growth metrics indicate that IOLCP has recently expanded revenue while delivering stronger per-share earnings. If sustained, this combination can improve internal funding capacity, reinforce competitive positioning, and support compounding operating performance.
Bears Say
Material Margin Compression
The sharp decline in gross and net margins shows that earnings quality and pricing power are materially weaker than at the FY2021 peak. Persistently lower profitability could limit reinvestment, reduce returns on capital, and make earnings more sensitive to cost or mix changes.
Weak And Volatile Free Cash Flow
Repeated negative free cash flow and weak conversion of profit into cash indicate that accounting earnings have not consistently translated into surplus funds. This can constrain internally financed expansion and reduce flexibility for dividends, debt reduction, or other capital allocation.
Uneven Revenue Trajectory
The recent pattern of flat revenue and consecutive annual declines before a modest rebound suggests that sustained demand expansion is not yet established. Uneven top-line performance can limit operating leverage and make future margin recovery harder to achieve.
IOL Chemicals & Pharmaceuticals Ltd. News
IOL Chemicals & Pharmaceuticals clears June quarter unaudited results with clean review
The latest update is out from IOL Chemicals & Pharmaceuticals Ltd. ( ($IN:IOLCP) ). IOL Chemicals and Pharmaceuticals Limited said its board has approved the company’s standalone and consolidated unaudited
IOL Chemicals wins Chinese approval for Clopidogrel Bisulfate API
IOL Chemicals & Pharmaceuticals Ltd. ( ($IN:IOLCP) ) has provided an announcement. IOL Chemicals and Pharmaceuticals Ltd. has received approval from China’s National Medical Products Administration for its Clopidogrel Bisulfate
IOL Chemicals & Pharmaceuticals Opens Special Window for Physical Share Demat and Backs Investor Campaign
IOL Chemicals & Pharmaceuticals Ltd. ( ($IN:IOLCP) ) has shared an announcement. IOL Chemicals & Pharmaceuticals has announced a one-time special window to facilitate the transfer-cum-dematerialisation of physical shares where
IOL Chemicals & Pharmaceuticals Defends Compliance of Q3 FY2025 Financial Results
IOL Chemicals & Pharmaceuticals Ltd. ( ($IN:IOLCP) ) has provided an announcement. IOL Chemicals & Pharmaceuticals has clarified to the National Stock Exchange that its standalone and consolidated financial results
IOLCP FAQ
What was IOL Chemicals & Pharmaceuticals Ltd.’s price range in the past 12 months?
What is IOL Chemicals & Pharmaceuticals Ltd.’s market cap?
When is IOL Chemicals & Pharmaceuticals Ltd.’s upcoming earnings report date?
How were IOL Chemicals & Pharmaceuticals Ltd.’s earnings last quarter?
Is IOL Chemicals & Pharmaceuticals Ltd. overvalued?
Does IOL Chemicals & Pharmaceuticals Ltd. pay dividends?
What is IOL Chemicals & Pharmaceuticals Ltd.’s EPS estimate?
How many shares outstanding does IOL Chemicals & Pharmaceuticals Ltd. have?
What happened to IOL Chemicals & Pharmaceuticals Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of IOL Chemicals & Pharmaceuticals Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
IOL Chemicals & Pharmaceuticals Ltd.
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Varinder Gupta
- Employees
- 3,592
- Website
- www.iolcp.com
- Address
- 85, Industrial Area 'A', Ludhiana, PU, 141003, IN
IOL Chemicals & Pharmaceuticals Ltd. (IOLCP) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 6 | 9 |
| Technical Analysis | 2 | 6 | 2 |
| Moving Averages | 5 | 0 | 7 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| IN:AARTIDRUGSAarti Drugs Limited | ||
| IN:GRANULESGranules India Limited | ||
| IN:HIKALHikal Limited | ||
| IN:NEULANDLABNeuland Laboratories Ltd. | ||
| IN:SOLARASolara Active Pharma Sciences Ltd. |







